MASP2 Deficiency
|
0.710 |
Biomarker
|
disease |
CTD_human |
|
|
|
MASP2 Deficiency
|
0.710 |
CausalMutation
|
disease |
CLINVAR |
|
|
|
Ulcerative Colitis
|
0.400 |
Biomarker
|
disease |
HPO |
|
|
|
Complement deficiency disease
|
0.400 |
Biomarker
|
group |
HPO |
|
|
|
Lupus Erythematosus, Systemic
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
Recurrent pneumonia
|
0.100 |
Biomarker
|
disease |
HPO |
|
|
|
MASP2 Deficiency
|
0.710 |
GermlineCausalMutation
|
disease |
ORPHANET |
Inherited deficiency of mannan-binding lectin-associated serine protease 2.
|
12904520 |
2003 |
MASP2 Deficiency
|
0.710 |
GeneticVariation
|
disease |
CLINVAR |
Inherited deficiency of mannan-binding lectin-associated serine protease 2.
|
12904520 |
2003 |
MASP2 Deficiency
|
0.710 |
GeneticVariation
|
disease |
UNIPROT |
Inherited deficiency of mannan-binding lectin-associated serine protease 2.
|
12904520 |
2003 |
Ulcerative Colitis
|
0.400 |
Biomarker
|
disease |
CTD_human |
Inherited deficiency of mannan-binding lectin-associated serine protease 2.
|
12904520 |
2003 |
Erythema Multiforme
|
0.300 |
Biomarker
|
disease |
CTD_human |
Inherited deficiency of mannan-binding lectin-associated serine protease 2.
|
12904520 |
2003 |
Immune Complex Diseases
|
0.300 |
Biomarker
|
group |
CTD_human |
Inherited deficiency of mannan-binding lectin-associated serine protease 2.
|
12904520 |
2003 |
Inflammation
|
0.300 |
Biomarker
|
phenotype |
CTD_human |
Inherited deficiency of mannan-binding lectin-associated serine protease 2.
|
12904520 |
2003 |
Streptococcal pneumonia
|
0.300 |
Biomarker
|
disease |
CTD_human |
Inherited deficiency of mannan-binding lectin-associated serine protease 2.
|
12904520 |
2003 |
MASP2 Deficiency
|
0.710 |
GeneticVariation
|
disease |
CLINVAR |
Mannan-binding lectin insufficiency in children with recurrent infections of the respiratory system.
|
15086395 |
2004 |
Cystic Fibrosis
|
0.020 |
AlteredExpression
|
disease |
BEFREE |
However, MBL or MASP-2 levels in serum did not affect the clinical outcome in the cohort of CF patients studied.
|
15654829 |
2005 |
Psoriasis
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Functional MASP2 single nucleotide polymorphism plays no role in psoriasis.
|
15948998 |
2005 |
MASP2 Deficiency
|
0.710 |
GeneticVariation
|
disease |
CLINVAR |
Low clinical penetrance of mannose-binding lectin-associated serine protease 2 deficiency.
|
17137870 |
2006 |
Cystic Fibrosis
|
0.020 |
GeneticVariation
|
disease |
LHGDN |
The mannan-binding lectin pathway and lung disease in cystic fibrosis--disfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier.
|
17045845 |
2006 |
Graft-vs-Host Disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Factors associated with a higher probability of IFIs were donor's MBL-low genotype (38% vs 12%, p = 0.01), recipient's MASP2 variant (67% vs 14%, p = 0.01), and acute graft-versus-host disease (GVHD) grades II to IV (27% vs 11%, p = 0.04); in the multivariate analysis MBL-low genotype (relative risk [RR] 7.3, p = 0.003), MASP2 variant (RR 6.4, p = 0.002), and acute GVHD II to IV (RR 3.8, p = 0.02) retained independent prognostic value.
|
16982337 |
2006 |
Angioedemas, Hereditary
|
0.010 |
Biomarker
|
disease |
BEFREE |
C1 inhibitor deficiency and deficiencies of MBL and MASP-2 were not included in the assessment.
|
16026838 |
2006 |
Squamous cell carcinoma of esophagus
|
0.010 |
AlteredExpression
|
disease |
BEFREE |
To determine the expression of MASP-2 protein, we raised a polyclonal antibody to human MASP-2 and used it for immunohistochemical analysis of MASP-2 in ESCCs.
|
16395704 |
2006 |
Acute GVH disease
|
0.010 |
GeneticVariation
|
disease |
BEFREE |
Factors associated with a higher probability of IFIs were donor's MBL-low genotype (38% vs 12%, p = 0.01), recipient's MASP2 variant (67% vs 14%, p = 0.01), and acute graft-versus-host disease (GVHD) grades II to IV (27% vs 11%, p = 0.04); in the multivariate analysis MBL-low genotype (relative risk [RR] 7.3, p = 0.003), MASP2 variant (RR 6.4, p = 0.002), and acute GVHD II to IV (RR 3.8, p = 0.02) retained independent prognostic value.
|
16982337 |
2006 |
Invasive Fungal Infections
|
0.010 |
GeneticVariation
|
group |
BEFREE |
Factors associated with a higher probability of IFIs were donor's MBL-low genotype (38% vs 12%, p = 0.01), recipient's MASP2 variant (67% vs 14%, p = 0.01), and acute graft-versus-host disease (GVHD) grades II to IV (27% vs 11%, p = 0.04); in the multivariate analysis MBL-low genotype (relative risk [RR] 7.3, p = 0.003), MASP2 variant (RR 6.4, p = 0.002), and acute GVHD II to IV (RR 3.8, p = 0.02) retained independent prognostic value.
|
16982337 |
2006 |
Infection
|
0.010 |
GeneticVariation
|
group |
LHGDN |
The mannan-binding lectin pathway and lung disease in cystic fibrosis--disfunction of mannan-binding lectin-associated serine protease 2 (MASP-2) may be a major modifier.
|
17045845 |
2006 |